About us
EN
» Home » About us

About us

Missions
Eurocord organization aims to promote the advancement of scientific academic and industrial research, the development of therapeutic applications and dissemination of knowledge related to the umbilical cord, placenta, annexes and more generally all that is within the field of materno-fetal interactions.

The goal of Eurocord organization is to unite around the same project, researchers, biologists and clinicians working on stem cells derived from cord blood, placenta and its annexes, to promote national and international collaborations and disseminate knowledge in this field through its site Eurocord-ED.

In order to expand this research Eurocord seeks for public and private partnerships.

Key points:

  1. Group focused on a single source of cells that does not pose any ethical or legal problem
  2. Easy access to cells
  3. Independent Non-profit Association
  4. Strong links with institutional organizations: Agence de Biomédecine, University Paris VII Institute Universitaire d’Hématologie, Assistance Publique des Hôpitaux de Paris
  5. A broad and multidisciplinary representation
  6. Priorities identified by a scientific committee composed of scientists involved in research and patients care
  7. Medicen Labelling and ownership of the mark Eurocord
  8. Active collaboration with national and international groups: EBMT( European Blood and Marrow Transplant Group, CIBMTR (Center for international bone marrow transplant Research) , Netcord , WMDA ( World Marrow Donor Association), WBMT (World Marrow Donor Transplant Group).

Program
A Education, Information and Dissemination
  1. Establish a funding plan for the development of researches and use of blood cells from umbilical cord and placenta
  2. Set up and develop a website with ESH and Eurocord-ED for information to the professionals and the general public
  3. Participate with the Biomedicine and EFS Agencies to the information and education of obstetricians, midwives, nurses, laboratory technicians, researchers and doctors in the program of information and education on cord cells and placenta.
  4. Organize a series of workshops and exchanges between the various participating centres
  5. Set up a website for information and exchanges with the general public with the Biomedicine agency


B Research
  1. Endothelial cells, mesenchymal, bone, cartilage, pancreas, blood from the umbilical cord.
  2. Placenta: collection of stem cells, pharmacology
  3. Family banks in families when a child has been diagnosed with a disease curable by stem cell transplant a focus will be put on the following diseases: Sickle cell disease, diabetes, hereditary non-hematologic diseases
  4. Optimizing conditions for the collection, cultivation and preservation of cells
C Clinical Studies
  1. Retrospective studies of hematopoietic stem cells transplants from umbilical cord blood
  2. Prospective studies of methods of facilitating the engraftment
  3. Design phase I II studies for gene therapy from umbilical cord blood of children with hereditary disorders collected at birth for ex Sickle cell disease.
  4. Phase I trials of cell therapy for non-hematological diseases eg diabetes, bone, cartilage diseases, arteritis.
  5. Implementation of a family bank cord blood and placenta in the family where an indication of transplant was established for a hematologic diseases.
  6. Design phase I II studies for clinical applications of cord blood and placenta cell therapies

June 21st 2010
The all-new Eurocord website is now online


» Read more